Format

Send to

Choose Destination
See comment in PubMed Commons below
Med Care. 2012 Oct;50(10):890-7.

Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods.

Author information

1
Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands. m.schuemie@erasmusmc.nl

Abstract

BACKGROUND:

Drug safety monitoring relies primarily on spontaneous reporting, but electronic health care record databases offer a possible alternative for the detection of adverse drug reactions (ADRs).

OBJECTIVES:

To evaluate the relative performance of different statistical methods for detecting drug-adverse event associations in electronic health care record data representing potential ADRs.

RESEARCH DESIGN:

Data from 7 databases across 3 countries in Europe comprising over 20 million subjects were used to compute the relative risk estimates for drug-event pairs using 10 different methods, including those developed for spontaneous reporting systems, cohort methods such as the longitudinal gamma poisson shrinker, and case-based methods such as case-control. The newly developed method "longitudinal evaluation of observational profiles of adverse events related to drugs" (LEOPARD) was used to remove associations likely caused by protopathic bias. Data from the different databases were combined by pooling of data, and by meta-analysis for random effects. A reference standard of known ADRs and negative controls was created to evaluate the performance of the method.

MEASURES:

The area under the curve of the receiver operator characteristic curve was calculated for each method, both with and without LEOPARD filtering.

RESULTS:

The highest area under the curve (0.83) was achieved by the combination of either longitudinal gamma poisson shrinker or case-control with LEOPARD filtering, but the performance between methods differed little. LEOPARD increased the overall performance, but flagged several known ADRs as caused by protopathic bias.

CONCLUSIONS:

Combinations of methods demonstrate good performance in distinguishing known ADRs from negative controls, and we assume that these could also be used to detect new drug safety signals.

PMID:
22929992
DOI:
10.1097/MLR.0b013e31825f63bf
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center